Clicky

Monday, November 16, 2026

Earnings

Results and financial condition

Cadiz Inc. reports Q3 results, shows $7.07 million loss
Latest

Cadiz Inc. reports Q3 results, shows $7.07 million loss

Cadiz Inc. reported a net loss of $7.07 million for Q3 2026, highlighting challenges in the water supply sector amid rising operational costs.

Ascentage Pharma's Drugs Included in China's Reimbursement List

IGI CEO to Present at Southwest IDEAS Investor Conference

Unicycive Therapeutics announces third-quarter results

Quarterly Reports

RADNOSTIX INC reports quarterly results for Q3 2026

Kartoon Studios Reports Third Quarter 2026 Financial Results

YAN CHUANG GROUP INC. Files Quarterly Report for Q3 2026

Annual Reports

VEON Ltd. Unveils 2030 Growth Strategy at Capital Markets Day

Pop Culture Group Co., Ltd Files Annual Report for 2026

Latest Earnings

1

FF EAI Robotics Ecosystem reports Q3 results amid challenges

2

Wetouch Technology Inc. Reports Q3 2026 Financial Results

3

AirJoule Technologies Reports Strong Q3 Results and Growth

4

Tribeca Strategic Acquisition Corp. files Q3 results

5

Atlantic Acquisition Corp I Releases Q3 Financial Results

More Earnings News

Stewards, Inc. Reports Strong Q3 Growth and Strategic Moves

Stewards, Inc. announces Q3 results, highlighting asset growth and strategic acquisitions, signaling a positive trend in the short-term business credit sector.

New Fortress Energy Reports Strong Q3 Results and Growth

New Fortress Energy Inc. announces positive Q3 results, showcasing growth in revenue and operational performance in the natural gas distribution sector.

INVO Fertility reports Q3 results, highlights operational updates

INVO Fertility, Inc. releases its Q3 report, detailing financial metrics and operational updates in the surgical and medical instruments sector.

BioAtla reports Q3 results, updates on product pipeline

BioAtla, Inc. releases its Q3 2026 financial results, highlighting advancements in its biological products pipeline and ongoing operational strategies.

Canton Strategic Holdings reports Q3 results and updates

Canton Strategic Holdings, Inc. files its Q3 report, detailing financial metrics and operational updates, impacting the finance services industry.

Kartoon Studios reports Q3 results, outlines financial health

Kartoon Studios, Inc. files Q3 report revealing financial performance and strategic updates in the motion picture production sector.

Nexentis Technologies reports Q3 results for 2026

Nexentis Technologies Inc. shares its Q3 2026 financial results, highlighting key developments in the pharmaceutical preparations sector.

Q/C Technologies Reports Q3 Results Amid Industry Challenges

Q/C Technologies, Inc. releases its Q3 report, highlighting financial updates and challenges in the diagnostic substances industry.

RANGE IMPACT, INC. Reports Q3 Results for 2026

RANGE IMPACT, INC. releases its Q3 2026 financial results, highlighting key performance metrics and strategic insights for the heavy construction sector.

MetaVia reports positive preclinical data for DA-1726

MetaVia Inc. shares promising preclinical results for DA-1726, a new obesity treatment, potentially enhancing its position in the pharmaceutical industry.

New Fortress Energy Reports Strong Q3 Results After Restructuring

New Fortress Energy Inc. announces robust Q3 results, revealing significant revenue growth and net income post-restructuring, signaling a transformative phase for the company.

Eloxx Pharmaceuticals reports Q3 results, advances trials

Eloxx Pharmaceuticals announces its Q3 financial results, highlighting progress in clinical trials for rare kidney diseases and FDA approvals.

GXO Logistics sets 2030 financial targets and 2027 outlook

GXO Logistics, Inc. outlines its 2030 financial goals and preliminary outlook for 2027, highlighting strategic growth initiatives ahead of Investor Day.

Aptevo Therapeutics reports Q3 results, highlights progress

Aptevo Therapeutics Inc. shares its Q3 financial results, focusing on advancements in pharmaceutical preparations and ongoing projects.

Eagle Financial Services to Merge with John Marshall Bancorp

Eagle Financial Services Inc. announces merger with John Marshall Bancorp, pending approvals. Shareholder vote set for November 19, 2026.

Ainos, Inc. reports third-quarter financial results

Ainos, Inc. announces its third-quarter financial results, showcasing its performance in the computer peripheral equipment industry.

StableCoinX Reports Strong Q3 2026 Results with Revenue Surge

StableCoinX Inc. announces impressive Q3 2026 results, with revenue rising nearly eightfold, driven by its Decentralized Verifier Node services.

Aptevo Therapeutics announces Q3 2026 financial results

Aptevo Therapeutics Inc. reports its Q3 2026 financial results, shedding light on its operational performance and industry trends.

Cycurion Reports Record Revenue Growth in Q3 2026 Results

Cycurion, Inc. announces a 40% increase in quarterly revenue, driven by acquisitions and returning growth in operations, as reported in their latest SEC filing.

Rein Therapeutics Reports Phase 2 Trial Data and Q3 Results

Rein Therapeutics announces encouraging Phase 2 trial data for LTI-03 and Q3 financial results, signaling potential advancements in pulmonary treatments.

Canton Strategic Holdings reports third-quarter results

Canton Strategic Holdings, Inc. announces its financial results for Q3 2026, showcasing its performance in the finance services sector.

Zenta Group Signs MOU for Strategic AI Acquisition

Zenta Group has signed a binding MOU to acquire a controlling stake in an AI technology start-up, enhancing its focus on AI and data solutions.

Virginia National Bankshares Corp reports Q3 results

Virginia National Bankshares Corp announces its third-quarter results, demonstrating resilience in the national commercial banking sector amid evolving market conditions.

Click Holdings Reports 45% Revenue Growth in Q1 FY2026/27

Click Holdings Ltd. announces over 45% revenue growth in Q1 FY2026/27, reflecting strong demand and strategic expansion in the employment services sector.

HCW Biologics reports Q3 results with operational updates

HCW Biologics Inc. files quarterly report, revealing financial updates and operational insights for Q3 2026.

More stories

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →